Previous genome-wide association studies (GWASs) have identified several loci associated with human height; however, such evidence was mostly reported in Caucasian populations. Since the different distributions of height between populations suggest their different genetic backgrounds, analysis in different populations would be useful. Here, we present the results of a GWAS for adult height in 19 633 Japanese subjects. We found eight significantly associated loci that satisfied the genome-wide significance level (P < 5.0 3 10 28 ). Of these, the association to the LHX3-QSOX2 locus was entirely novel (rs12338076, P 5 2.2 3 10 28 ). We also identified the association to the IGF1 locus (rs17032362, P 5 8.1 3 10 29 ). Conditional association analysis in the IGF1 locus with rs17032362 suggested the existence of an additional independent association with height to this locus (rs1457595, P 5 1.2 3 10 25 ). We observed large differences in the allele frequencies of rs17032362 and rs1457595 between Japanese (34 and 9%, respectively) and Caucasian (1.7 and 0%, respectively) populations, thereby suggesting weak statistical powers for the IGF1 locus in the previous Caucasian GWASs for height. We extensively compared our results with those of previous reports on the Caucasian and Korean populations. We were able to replicate all four loci previously reported in Koreans (EFEMP1, ZBTB38, HMGA1 and PLAG1, P < 5.0 3 10
INTRODUCTION
Heritability of human height has been reported to be 80-90%, which is one of the highest among human physical quantitative traits (1) . Since 2008, the genome-wide association studies (GWASs) conducted using single nucleotide polymorphisms (SNPs) have detected many genetic loci associated with human height (2 -12) . Gudbjartsson et al. (6) found 27 loci whereas Weedon et al. (4) reported 20 loci; however, these loci explained only a few percent of the variance of height. For example, the SNPs identified by Gudbjartsson et al. (6) explained only 3.7% of height variance. These observations suggest that there are still many unidentified genetic variants for height that need to be investigated (13) .
There are differences in the distribution of height between different populations. In the Japanese population, we have observed a great increase in the average height during the † Y.O. and Y.K. contributed equally to this study. * To whom correspondence should be addressed at: CGM, RIKEN, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, Kanagawa 230-0045, Japan. Tel: +81 455039111; Fax: +81 455039113; Email: kamatani@msb.biglobe.ne.jp past century [increases of around 10 cm both in males and females from 1950s to 2000s (14) ]. However, the difference in average height between the Japanese and British populations was about one standard deviation even in 1977 (15) . The increase in height during the past century was mostly due to the improvement of nutritional conditions or the urbanization of dietary habit in Japan (16) . Although the difference in height between Japanese and Europeans has decreased, there is still a substantial height difference between the two populations. This difference might be attributable to either genomic factors or gene-environment interactions. Although previous GWASs identified numerous genetic loci associated with height, these studies were mostly conducted in Caucasian populations. Except for a few studies in the Korean population (9, 12) , association studies for height in Asian populations have not been assessed further. Therefore, a GWAS for height in the Japanese population might lead to the identification of novel associated loci, since it can be assumed that some heightassociated loci, difficult to detect in other populations, would show significant associations in the Japanese population.
We performed a large-scale GWAS for adult height by using genome-wide SNP genotype data from 19 633 Japanese subjects. The study population consisted of patients in 23 disease sample groups from the BioBank Japan Project (17) , and healthy volunteers. We also compared our results with previous reports describing height loci (2 -12) and discussed the differences in the height-associated loci between Caucasian and Asian populations.
RESULTS

Genome-wide meta-analysis
The entire sample was composed of 19 633 Japanese subjects from 23 disease sample groups and a healthy control group (Supplementary Material, Table S1 ). All the subjects were of Japanese origin. The genotypes for 420 885 SNPs that fulfilled our quality control criteria were used for the analysis. The heights were adjusted in each sample group for gender, age and the top 10 eigenvectors from principal component analysis (PCA) for population stratification, so that the adjusted values follow the standard normal distribution as described in the Materials and Methods. The adjusted values were used for the genome-wide analysis in each sample group, and the meta-analysis of the results of the genome-wide analysis of the sample groups was performed using the inverse-variance method.
A quantile -quantile plot of the test statistic of genome-wide meta-analysis for 420 885 SNPs is shown in Supplementary Material, Fig. S1 . The inflation factor of the test statistic, l GC (18), was 1.113, which appeared to be slightly higher when compared with those reported in previous studies for height (2 -6,9 -11) . To evaluate the possibility that the potential population stratification within or among the sample groups might have been induced, we compared the l GC of the respective sample groups. The l GC of the sample groups did not demonstrate apparent discrepancies from 1.00 (0.98 -1.02; Supplementary Material, Fig. S2 ). Two-dimensional displays of the results of the PCA analysis for our samples along with HapMap populations (19) demonstrated that our samples are rather homogenous and concord with the HapMap Japanese (JPT) and Han Chinese (CHB) populations (Supplementary Material, Fig. S3 ). The sample groups were closely clustered in their distributions for PCA analysis and did not indicate inter-group discrepancies (Supplementary Material, Fig. S4 ). One explanation of the relatively high l GC value observed in our study could be the large sample size used, because the l GC value increases with an increase in sample size (20, 21) . When the l GC value for the genomewide meta-analysis for all the groups was adjusted to a sample size of 1000, it became as small as 1.006. To robustly confirm the results of our study, we applied the genomic control method (18) to adjust P-values in our study.
Through meta-analysis, we identified eight loci that satisfied the genome-wide significance level (P , 5.0 × 10
28
; Table 1 , Fig. 1 ). Among them, six loci that were most significantly associated with height had been reported in the previous GWASs, and our results confirmed the associations with the following loci; NCAPG-LCORL (4,6,8), HMGA1 (6, 8, 9, 12) , PLAG1 (6, 8, 9, 12) , EFEMP1 (4,6,9,12), ZBTB38 (3) (4) (5) (6) 8, 9, 12) and DIS3L2 (6,10) loci (P ¼ 7.9 × 10 215 , 1. , respectively). The other two loci (LHX3-QSOX2 and IGF1) had not been previously associated with height at the genomewide significance level. Therefore, we imputed missing genotypes at the loci and reevaluated the association of the SNPs (see the following sections). SNPs which showed P-values lower than 1.0 × 10
25
, but did not reach the genome-wide significance level, are also shown in Table 1 . Among them, the associations with LTBP1 (9,12), ADAMTSL3 (4 -6,8), (4, 6) and GLT25D2 (6) were replications from previous reports. No significant heterogeneity of the effect size was observed through the loci identified in the genome-wide meta-analysis (P for Cochran's Q ≥ 0.05; low degree of heterogeneity with I 2 ≤ 25%), except for the PDXDC1-NTAN1 locus (P for Cochran's Q ¼ 0.0024; moderate degree of heterogeneity with 25% , I 2 ≤ 50%).
Associations to the LHX3-QSOX2 locus
We identified a significant association to a SNP in the LHX3-QSOX2 locus (P ¼ 2.2 × 10 28 , rs12338076; Table 1 ). The SNP rs12338076 was also the most significantly associated SNP after the imputation of the missing genotypes ( Fig. 2A) . This locus was entirely novel as a height-associated locus. LHX3 is a member of LIM-homeodomain (LIM-HD) transcription factors. LHX3 encodes a transcription factor that can bind to regulatory elements in the promoters/enhancers of pituitary genes and plays a substantial role in pituitary development (22) . Mutations in this gene were reported to be associated with a syndrome of combined pituitary hormone deficiency and vertebral malformations (23) , which supported our findings of the association with adult height from the functional viewpoint. The role of QSOX2 in the mechanism of growth would be unclear.
Associations to the IGF1 locus
We also identified the association of the height to the IGF1 locus (P ¼ 3.9 × 10 28 , rs5742692; Table 1 ). After the Table 2 and Fig. 2B ). These associations encompassed several genes such as CCDC53, NUP37, C12orf48, PMCH and IGF1. Of these loci, IGF1 seems to be the gene most responsible for adult height quantitative trait locus (QTL) from the functional point of view (24, 25) . Although IGF1 is a well-known gene that plays an important role in skeletal development (24, 25) , the association of the variation in this gene with adult height has not been reported with substantial evidence in previous studies (2) (3) (4) (5) (6) (7) (8) (10) (11) (12) 26) .
When we performed conditional analysis of this locus with the most significantly associated SNP rs17032362, associations to the SNPs in the downstream region of IGF1 gene diminished. Instead, another peak of the association was observed at about 0.1 Mb upstream of IGF1 (P ¼ 1.2 × 10 25 , rs1457595; Table 2 and Fig. 2C ), thereby suggesting the existence of an additional independent association of the IGF1 locus with height.
We extensively evaluated the association of the two SNPs previously reported to be associated with height in the IGF1 locus (rs35767 and rs1520223) (12, 27) . The SNP rs35767 (2G1245A) is known to be in linkage disequilibrium (LD) with the 192 bp CA-repeat in the promoter region of the IGF1 gene, which is the most commonly investigated polymorphism in this locus (27) . A suggestive association to rs1520223 was indicated in a previous GWAS in the Korean population (12) . We replicated the associations to both SNPs (P ¼ 0.0034 and P ¼ 2.8 × 10 27 , respectively; Table 2 ); however, the association was diminished when conditioned with the most significantly associated SNP rs17032362 (P ¼ 0.76 and P ¼ 0.61, respectively; Table 2 ). Conversely, the association of rs17032362 was still significant after conditioning with each of the reported SNPs (P ¼ 2.3 × 10 27 and P¼0.0046, respectively). These results suggested that the associations to these previously suggested SNPs reflected the association to rs17032362 via LD with it, at least in the Japanese population.
Interestingly, the height-associated SNPs in the IGF1 locus demonstrated large differences in allele frequency between the Japanese and Caucasian populations (19) . The minor allele frequency for the height-associated SNPs rs17032362 and rs5742692 ranged as high as 26-38% in the subjects of our study population or in the HapMap Japanese (JPT) population, although their frequency in the HapMap Caucasian (CEU) population were as low as 1.7%. The minor allele frequency for rs1457595 was 8 -9% in the Japanese population, but monomorphic in the HapMap CEU population.
Comparison with previous reports
We evaluated the previously reported height-associated loci (Table 3) . We selected 40 loci that showed significant associations (P , 5.0 × 10
28
) in previous GWASs, published before 31 December 2009 for human height (2 -12) . Table 3 shows the P-values obtained when the reported SNPs were genotyped in our study, or while imputed results are shown otherwise. When more than one SNP in the same locus was reported, the SNP that demonstrated the most significant P-value in our study population was indicated. P-values lower than 0.001 were considered to be significant accounting for the correction for multiple testing of the 40 independent 
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loci. We also estimated the statistical power of the previously reported loci in our study population. Among the 40 selected loci, we replicated the associations to 15 loci with the same directions of the effects of the alleles. Among the 24 loci that had statistical powers more than 80%, 12 were replicated. Conversely, only 3 of the 16 loci with a statistical power ,80% were replicated. All of the four significantly associated loci identified in a Korean study (9) (EFEMP1, ZBTB38, HMGA1 and PLAG1) were clearly associated in our study at the genome-wide significance level (P , 5.0 × 10
28
), suggesting similarities in the genetic background for height in the Korean and Japanese populations. We replicated the associations to 15 of the 40 loci reported for Caucasians (SPAG17, EFEMP1, DIS3L2, ZBTB38, NCAPG-LCORL, HHIP, HMGA1, GPR126, GNA12, PLAG1, DLEU7, TIP11-ATXN3, ADAMTSL3, CABLES1 and GDF5-UQCC, P , 0.001). Although the SNPs in three loci (GLD25D2, IHH and LIN28B) did not show significant P-values, we observed strong association to closely positioned observed SNPs (GLD25D2, rs756199, P ¼ 7.5 × 10
26
; IHH, rs16859517, P ¼ 4.2 × 10 26 ) or imputed SNPs (LIN28B, rs314280, P ¼ 1.8 × 10
24
). In these three loci, higher degrees of LD between the associated SNPs in our GWAS and the previously reported SNPs were observed in HapMap JPT individuals (r 2 ¼ 0.697, 0.121 and 0.302, respectively) than in CEU individuals (r 2 ¼ 0.241, 0.008 and 0.134, respectively). In contrast, the other 22 loci did not show significant association.
Combined effects of the height-associated loci
We evaluated the combined effects of the height-associated loci. Each subject was assigned with a normalized Z score on the basis of the weighted number of height-increasing alleles of the SNP at each locus. When the 25 SNPs that indicated significant or suggestive associations in our GWAS (P , 1.0 × 10
25
) were combined, the model explained 3.9% of the total variance of height in our study population. When we included the SNPs previously associated with height (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) in the model, the contribution to the variance was 4.6%. The additive effect size was 1.26 cm per 1.0 increase in the normalized Z score (95% confidence interval: 1.18-1.34; Fig. 3 ). There was a 6.5 cm of difference in the mean heights between individuals with Z scores less than or equal to 22 and ≥2.
DISCUSSION
We identified eight significantly associated height QTLs through a genome-wide QTL study for adult height, using the data from 19 633 Japanese subjects. Among them, the LHX3-QSOX2 locus was novel. We also confirmed the association of the IGF1 locus with height. IGF1 belongs to a family of proteins involved in mediating growth, and its role in skeletal development is apparent (24, 25) . Although, the contribution of the IGF1 locus to height has been suggested (28) , previous studies in Caucasian populations did not identify a significant association between variations in IGF1 and adult height (2 -8,10,11,26) . A GWAS in the Korean population suggested the association in IGF1 locus with height (12); however, its association did not satisfy the genome-wide significance level of P , 5.0 × 10
28
. To the best of our knowledge, this study is the first report confirming the association of the IGF1 locus with height at the genome-wide significance level. Moreover, our results suggest the existence of an additional association with height, independent of the most significantly associated SNP in our GWAS.
We identified that the minor allele frequencies of heightassociated SNPs in the IGF1 locus were high in the Japanese population, but quite rare or even monomorphic in Caucasian populations. The low statistical power in Caucasians due to the low minor allele frequencies would partly explain why this height QTL has not been detected in previous Caucasian GWASs (2 -8,10,11,26) . This observation also suggests the presence of different genetic backgrounds for human height among different populations. Although the contribution of the IGF1 locus itself would be too small to explain the height differences between Asians and Europeans, it would be one of the pieces of evidence that there exist numerous height-associated variations with different allele frequencies between populations, and their accumulations yield the height differences among them.
Nevertheless, other possible explanations include different effect sizes for the same variations, different gene -gene or gene -environment interactions, or the difference in LD structure in the region between the two populations. In fact, the most significant SNP in LHX3-QSOX2 locus, rs12338076, has similar minor allele frequencies in our Japanese samples (33.8%) and HapMap CEU populations (30.8%). These results may indicate that rs12338076 has different effect sizes between the two populations or another unidentified SNP that is associated with the former SNP in different LD structures between the populations may be directly associated with the height.
On comparing our results with that of previous reports, we found that all the four loci identified in a previous study in the Korean population (9) were included in the eight loci we identified with genome-wide significance. These four loci, HMGA1, PLAG1, EFEMP1 and ZBTB38, might play common roles in the genetics of adult human height in Asian populations. In contrast, some of the loci identified in the Caucasian population did not show significant associations in our study. The association of adult height with DNM3 (6,8),  HIST1H1D (5,8), JAZF1 (7,8), CDK6 (4 -6,8,9 ) and HMGA2 (4 -6,8) have been reported by more than one study, and it is unlikely that these reports represent false positive results. One probable explanation for the lack of replication to these loci is the low statistical power mostly due to the different allele frequencies of the SNPs among the populations. However, the DNM3, CDK6 and HMGA2 loci had more than an 80% estimated statistical power in our study population, and the failure to detect the associations to these loci could be due to the different effect sizes of the SNPs among population, or gene -gene or gene -environment interactions, as previously discussed. Alternatively, the causative variations may be different from the observed SNPs and the frequencies of the causative alleles could be quite different among populations. The observed SNPs may have demonstrated significant association in previous studies but not in our study because of different LD patterns with the causative SNPs. These results suggest the importance of the accumulation of studies in different populations to elucidate the unidentified genetic etiology of human height.
We evaluated the combined effects of the height-associated loci by scoring individuals with the number of heightincreasing alleles. We weighted the effects of the respective loci based on their effect size and this enabled us to account for the differences of the effect size among the loci. However, the proportion of the variance of height explained by the model was as low as 4.8%, even when all of the loci identified in the present study and in previous studies were incorporated together. In addition, it would be probable to assume the observed proportion of variance may be overestimated because of the 'winner's curse effect', i.e. the overestimation of the genetic effect size in the initial studies (29) . These results would suggest that most of the loci associated with human height are still unidentified (4 -6) .
In summary, through a GWAS for adult height using 19 633 Japanese subjects, we identified the LHX3-QSOX2 and IGF1 as associated loci. We were able to replicate all the four associations previously reported in the Korean population and 15 of the 40 associations reported in the Caucasian population. Large differences in minor allele frequencies of heightassociated SNPs in IGF1 provide evidence of the different genetic backgrounds of human height underlying different populations.
MATERIALS AND METHODS
Samples
Members of the Midosuji Rotary Club (MRC, Osaka, Japan) participated in this study as healthy volunteers. Other samples used in this study were selected from the BioBank Japan Project (17) . The BioBank Japan Project was started in 2003 for the collection of genomic DNA, serum and clinical information from about 300 000 patients diagnosed with any of the 47 diseases by a collaborative network of 66 hospitals in Japan (http://biobankjp.org). All the subjects reported themselves to be of Japanese origin. The individuals who were determined to have a non-Japanese ancestry by PCA were excluded from the study populations (as described below). Written informed consent was obtained from all of the subjects. The characteristics of each study population are shown in Supplementary Material, Table S1 .
Collection of clinical data
The height, gender and age of the healthy MRC volunteers were collected by questionnaire at entry. The clinical information of the subjects from the BioBank Japan Project (17) was collected annually from a uniform questionnaire (height) or medical records (gender and age). Although the assessment of bias induced by self-reported data may be concern, we considered that such bias would not be a significant obstacle in the analysis as previously reported (30) . Samples with missing clinical data were excluded from the analyses. Subjects who were ,18 years of age were also excluded. Finally, 19 633 subjects were obtained for the further association study (Supplementary Material, Table S1 ).
Genotyping of SNPs
Ten study populations were genotyped using the Illumina Human610-Quad BeadChip (Illumina, CA, USA), although the other 14 populations were genotyped using the Illumina HumanHap550 BeadChip (Illumina, CA, USA; Supplementary Material, Table S1 ). All of these experiments were performed at the same institute by the same technical staff (Center for Genomic Medicine, RIKEN). Quality control of the genotype data were performed in each GWAS using the following criteria. First, samples with call rates lower than 0.98 were excluded. Then, from the samples with a call rate ≥0.98, the SNPs with call rates lower than 0.99 or SNPs with ambiguous clustering of the intensity plots visually as identified by the trained staff, were excluded from the following analyses.
Statistical analysis
From the 544 784 common autosomal SNPs generated using HumanHap550 and Human610-Quad BeadChips, 481 668 SNPs fulfilled the quality control criteria. We also excluded SNPs with minor allele frequencies ,0.01 or with P-values lower than 1.0 × 10 27 from the exact Hardy -Weinberg equilibrium test (31) , and as a result, the number of SNPs used for the analysis was 422 488. The genotype data of these SNPs from all subjects were submitted to the evaluation of population stratification using EIGENSTRAT software version 2.0 (32) together with four HapMap populations [Japanese in Tokyo (JPT), Han Chinese in Beijing (CHB), Yoruba in Nigeria (YRI) and Utah residents with Northern and Western European ancestry from the CEPH collection (CEU)] (19) . By using the eigenvectors 1 and 2, which clearly divided the four HapMap populations into three clusters (21), we excluded five subjects who were apparent outliers of the Asian cluster. The EIGENSTRAT software was applied again for each sample group to calculate the eigenvectors used for the following analysis.
A linear regression model was applied to adult height by incorporating gender, age and the top 10 eigenvectors as covariates in each sample group, and the residuals were then normalized to be adjusted heights, using R statistical software. Even though not all of the eigenvectors indicated significance in each sample group (a ¼ 0.05 for Tracy -Widom statistic), we incorporated all of the 10 eigenvectors in the regression model to robustly correct the effect of potential population stratification. The association of the SNPs with height was evaluated using a linear regression model assuming additive effects of the alleles (0, 1 and 2) on the adjusted height, by '-linear' option implemented in PLINK version 1.06 (33) . The results from the linear regression analysis in each sample group were combined by inverse-variance meta-analysis from the summary statistic b and the standard error (SE) (2), using a Perl source code implemented by the authors. The heterogeneity of the effect size of the SNPs among the sample groups was evaluated using Cochran's Q statistic and its metric I 2 (34) . I 2 is a measure of the percentage of total variation across studies due to heterogeneity beyond chance. I 2 values of 0-25%, 25-50%, 50-75% and 75-100% were assigned as low, moderate, large and extreme degrees of heterogeneity, respectively (34) . From the genomewide meta-analysis results, the inflation factor of the test statistic, l GC , was calculated to be 1.113, and this value was used for the correction of the obtained P-values using the genomic control method (18) . P-values corrected by the genomic control method were presented as the final results. The fraction of variance explained by an associated SNP was calculated by 2f (1-f ) a 2 , where f is the frequency of an allele and a is its standardized coefficient (6) . Conditional analysis of the locus with the most significantly associated SNP was performed by '-condition' option implemented in PLINK version 1.06 (33) .
Imputation of missing genotypes was performed using MACH 1.0 (see Software). The genotype data of JPT and CHB individuals obtained from the Phase II HapMap database (release 24) (19) were used as reference data. The region located +500 kb around the most significantly associated genotyped SNP in each locus was imputed. In the process of imputation, 50 Markov Chain iterations were implemented. Imputed SNPs with an imputation quality score of (Rsq values) ,0.3 were excluded from the analysis.
The statistical power of the linear regression analysis for the SNP in each of the previously reported loci was calculated by the cumulative distribution of a significant level in the noncentral t distribution with ncp = b 0 2nf (1 − f ) √ , where b 0 is the effect size on the normalized trait reported in the original study, n is sample size of our study population and f is the observed frequency of the tested allele in our sample population.
We assessed a total of 51 loci including the 25 loci that indicated significant or suggestive associations in our GWAS (P , 1.0 × 10
25
; Table 1 ) and the previously suggested loci (Table 3) in the analysis for the combined effects of the height-associated loci. A total of 19 487 subjects with complete genotypes at all markers were analyzed. For the loci included in our GWAS and the previous GWASs, the SNP with the most significant association was selected. Each individual was scored as the sum of the products of the number of height-increasing alleles of the SNP (0, 1 and 2) and the absolute values of the effect size of the SNP in our study populations. The scores were then normalized as Z scores. The effects of the Z scores on height were evaluated using the multivariate linear regression model incorporating height as a dependent variable and the Z scores, gender and age as the independent variables, using R statistical software. Differences in height between the subjects with low Z scores (less than or equal to 22) and high Z scores (≥2) were obtained by comparing the means of the non-adjusted height between subject groups.
Software
PCA was performed using EIGENSTRAT version 2.0 (32). Linear regression analysis in each sample group was performed using PLINK version 1.06 (33) . SNP genotype imputation was performed using MACH 1.0 (http://www.sph. umich.edu/csg/abecasis/MaCH/index.html). Inverse-variance meta-analysis was performed using a Perl source code implemented by the authors. The R statistical environment version 2.9.0 (http://www.r-project.org/) was used for the other analyses.
